Pharmacokinetics of RSD921, a new sodium channel blocking agent: a phase I study (2002)
Source: British Journal of Clinical Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Leonardo Augusto e RIBEIRO, Wellington e DE NUCCI, Gilberto. Pharmacokinetics of RSD921, a new sodium channel blocking agent: a phase I study. British Journal of Clinical Pharmacology, v. 53, n. 4, p. 440-441, 2002Tradução . . Acesso em: 15 out. 2024.APA
Moraes, L. A., Ribeiro, W., & De Nucci, G. (2002). Pharmacokinetics of RSD921, a new sodium channel blocking agent: a phase I study. British Journal of Clinical Pharmacology, 53( 4), 440-441.NLM
Moraes LA, Ribeiro W, De Nucci G. Pharmacokinetics of RSD921, a new sodium channel blocking agent: a phase I study. British Journal of Clinical Pharmacology. 2002 ; 53( 4): 440-441.[citado 2024 out. 15 ]Vancouver
Moraes LA, Ribeiro W, De Nucci G. Pharmacokinetics of RSD921, a new sodium channel blocking agent: a phase I study. British Journal of Clinical Pharmacology. 2002 ; 53( 4): 440-441.[citado 2024 out. 15 ]